Emerging applications of cancer bacteriotherapy towards treatment of pancreatic cancer

Pancreatic cancer is a highly aggressive form of cancer with a five-year survival rate of only ten percent. Pancreatic ductal adenocarcinoma (PDAC) accounts for ninety percent of those cases. PDAC is associated with a dense stroma that confers resistance to current treatment modalities. Increasing r...

Descripción completa

Detalles Bibliográficos
Autores principales: Henderson, Emily A., Lukomski, Slawomir, Boone, Brian A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425600/
https://www.ncbi.nlm.nih.gov/pubmed/37588093
http://dx.doi.org/10.3389/fonc.2023.1217095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425600/
https://www.ncbi.nlm.nih.gov/pubmed/37588093
http://dx.doi.org/10.3389/fonc.2023.1217095

Ejemplares similares